2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Whitmore Bradford T | 10% Owner | 2,350,152 | Feb 9, 2024 |
| Ingram Robert Alexander | 10% Owner | 2,060,514 | Jan 19, 2017 |
| Lee Kenneth B Jr | 10% Owner | 2,060,514 | Jan 19, 2017 |
| Crumpler John | 10% Owner | 2,060,514 | Jan 19, 2017 |
| Reed Douglas MD | 10% Owner | 2,060,514 | Jan 19, 2017 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Feb 24, 2025 | Thorp Clay | Director | Buy | 86.3 | +15,000 | 9.31% | ✗ | $13.8K |
| Jan 8, 2025 | Jan 10, 2025 | Deignan Charles A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 8, 2025 | Jan 10, 2025 | Chong Ngai Hang Victor | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 8, 2025 | Jan 10, 2025 | LASEZKAY GEORGE M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 1, 2024 | Nov 4, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy | 91.3 | +36,500 | 57.48% | ✗ | $36.5K |
| Jun 24, 2024 | Jun 24, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Buy | 91.3 | +23,500 | 58.75% | ✗ | $24.9K |
| Jun 24, 2024 | Chong Ngai Hang Victor | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 20, 2024 | Jun 21, 2024 | Gibney Anthony S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | YERXA BENJAMIN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Hutson Nancy J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Croarkin Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | EDWARDS JEFFREY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Humphries William D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | Thorp Clay | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 21, 2024 | SHAFFER CHRISTY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2024 | May 15, 2024 | YERXA BENJAMIN R | Director | Buy | 91.3 | +7,813 | 77.02% | ✗ | $10.2K |
| Apr 17, 2024 | Apr 19, 2024 | Gibney Anthony S | Director | Buy | 95.0 | +100,000 | 100.00% | ✗ | $129.7K |
| Apr 15, 2024 | Apr 16, 2024 | Gibney Anthony S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 16, 2024 | Gibney Anthony S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 20, 2024 | Mar 20, 2024 | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | Buy | 91.3 | +30,000 | 100.00% | ✗ | $48K |
| Mar 18, 2024 | Mar 18, 2024 | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 18, 2024 | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 7, 2024 | Feb 9, 2024 | WHITMORE BRADFORD T | 10% Owner | Buy | 92.5 | +444,444 | 6.94% | ✗ | $600K |
| Jan 19, 2024 | Jan 19, 2024 | LASEZKAY GEORGE M | CEO | Sell | 46.3 | -18,000 | -3.71% | ✗ | $22.9K |
| Jan 19, 2024 | Jan 19, 2024 | Deignan Charles A. | CFO | Sell | 46.3 | -12,900 | -3.24% | ✗ | $16.5K |
| Oct 30, 2023 | Nov 1, 2023 | WHITMORE BRADFORD T | 10% Owner | Buy | 82.5 | +135,778 | 2.17% | ✗ | $99.8K |
| Nov 1, 2023 | WHITMORE BRADFORD T | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 3, 2023 | Oct 4, 2023 | Hutson Nancy J | Director | Buy | 90.0 | +10,000 | 12.05% | ✗ | $8.6K |
| Sep 25, 2023 | Sep 25, 2023 | Thorp Clay | Director | Buy | 60.0 | +10,000 | 0.28% | ✗ | $8.6K |
| Sep 22, 2023 | Sep 22, 2023 | Humphries William D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 18, 2023 | Sep 20, 2023 | Deignan Charles A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 18, 2023 | Sep 20, 2023 | LASEZKAY GEORGE M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 13, 2023 | Sep 13, 2023 | Deignan Charles A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | Thorp Clay | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | Croarkin Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | EDWARDS JEFFREY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | Humphries William D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | Hutson Nancy J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | SHAFFER CHRISTY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2023 | Jun 23, 2023 | YERXA BENJAMIN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 20, 2023 | Jan 20, 2023 | Ciulla Thomas | Chief Medical Officer | Sell | 41.3 | -13,700 | -4.48% | ✓ | $20.1K |
| Jan 19, 2023 | Jan 20, 2023 | LASEZKAY GEORGE M | CEO | Sell | 41.3 | -20,030 | -3.97% | ✓ | $29.2K |
| Jan 19, 2023 | Jan 20, 2023 | Deignan Charles A. | CFO | Sell | 41.3 | -14,030 | -3.72% | ✓ | $21K |
| Jan 10, 2023 | Jan 11, 2023 | Ciulla Thomas | Chief Medical Officer | Sell | 52.5 | -2,170 | -0.71% | ✓ | $3.5K |
| Jan 4, 2023 | Jan 6, 2023 | LASEZKAY GEORGE M | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 4, 2023 | Jan 6, 2023 | Deignan Charles A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 30, 2022 | Jan 6, 2023 | Ciulla Thomas | Chief Medical Officer | Neutral | 82.5 | +10,000 | 3.36% | ✗ | - |
| Dec 21, 2022 | Dec 21, 2022 | Thorp Clay | Director | Buy | 61.3 | +14,000 | 0.39% | ✗ | $14.3K |
| Dec 20, 2022 | Dec 20, 2022 | Deignan Charles A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 15, 2022 | Dec 19, 2022 | Thorp Clay | Director | Neutral | 27.5 | -1,397,985 | -28.19% | ✗ | - |
| Feb 10, 2021 | Dec 19, 2022 | Thorp Clay | Director | Sell | 47.5 | -32,873 | -0.66% | ✓ | $145.6K |
| Nov 17, 2022 | Nov 21, 2022 | Hutson Nancy J | Director | Buy | 91.3 | +30,000 | 56.60% | ✗ | $39.9K |
| Jun 22, 2022 | Jun 24, 2022 | SHAFFER CHRISTY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | YERXA BENJAMIN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Hutson Nancy J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Croarkin Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | EDWARDS JEFFREY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Humphries William D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2022 | Jun 24, 2022 | Thorp Clay | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2022 | Mar 4, 2022 | YERXA BENJAMIN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2022 | YERXA BENJAMIN R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 18, 2022 | Jan 28, 2022 | Ciulla Thomas | Chief Medical Officer | Neutral | 90.0 | +46,250 | 18.10% | ✗ | - |
| Jan 18, 2022 | Jan 28, 2022 | Deignan Charles A. | CFO | Neutral | 90.0 | +46,250 | 14.62% | ✗ | - |
| Jan 18, 2022 | Jan 20, 2022 | Deignan Charles A. | CFO | Sell | 91.3 | +34,917 | 11.03% | ✓ | $18.5K |
| Jan 18, 2022 | Jan 20, 2022 | Ciulla Thomas | Chief Medical Officer | Sell | 86.3 | +34,700 | 6.20% | ✓ | $19.3K |
| Jan 18, 2022 | Jan 20, 2022 | LASEZKAY GEORGE M | CEO | Sell | 91.3 | +86,700 | 20.75% | ✓ | $22.9K |
| Jan 11, 2022 | Jan 13, 2022 | LASEZKAY GEORGE M | CEO | Sell | 48.8 | -5,100 | -1.21% | ✓ | $12.5K |
| Jan 10, 2022 | Jan 11, 2022 | Humphries William D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 29, 2021 | Nov 2, 2021 | Hutson Nancy J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2021 | Sep 23, 2021 | Ciulla Thomas | Chief Medical Officer | Sell | 51.3 | -2,560 | -0.99% | ✓ | $16.4K |
| Sep 21, 2021 | Sep 23, 2021 | LASEZKAY GEORGE M | CEO | Sell | 51.3 | -3,525 | -0.83% | ✓ | $22.8K |
| Sep 21, 2021 | Sep 23, 2021 | Deignan Charles A. | CFO | Sell | 51.3 | -2,800 | -0.88% | ✓ | $17.9K |
| Aug 30, 2021 | Sep 1, 2021 | WHITMORE BRADFORD T | 10% Owner | Sell | 17.5 | -420,285 | -6.60% | ✗ | $2.9M |
| Aug 16, 2021 | Aug 17, 2021 | Hutson Nancy J | Director | Buy | 91.3 | +3,000 | 30.00% | ✗ | $17K |
| Jun 21, 2021 | Jun 23, 2021 | LASEZKAY GEORGE M | CEO | Sell | 51.3 | -3,707 | -0.86% | ✓ | $16.2K |
| Jun 21, 2021 | Jun 23, 2021 | Deignan Charles A. | CFO | Sell | 51.3 | -2,938 | -0.91% | ✓ | $12.8K |
| Jun 10, 2021 | Jun 11, 2021 | Hutson Nancy J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | Croarkin Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | EDWARDS JEFFREY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | Humphries William D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | Thorp Clay | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | SHAFFER CHRISTY L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 19, 2021 | Mar 23, 2021 | LASEZKAY GEORGE M | CEO | Sell | 52.5 | -3,370 | -0.78% | ✓ | $9.5K |
| Mar 12, 2021 | Mar 15, 2021 | Hutson Nancy J | Director | Buy | 91.3 | +5,000 | 100.00% | ✗ | $15.5K |
| Mar 2, 2021 | Mar 3, 2021 | LASEZKAY GEORGE M | CEO | Sell | 48.8 | -6,000 | -1.36% | ✓ | $20.2K |
| Mar 1, 2021 | Mar 3, 2021 | Ciulla Thomas | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 10, 2021 | Feb 12, 2021 | Thorp Clay | Director | Sell | 47.5 | -32,873 | -0.95% | ✓ | $145.6K |
| Jan 18, 2021 | Jan 20, 2021 | LASEZKAY GEORGE M | CEO | Neutral | 90.0 | +140,250 | 46.85% | ✗ | - |
| Jan 18, 2021 | Jan 20, 2021 | Deignan Charles A. | CFO | Neutral | 90.0 | +96,360 | 42.67% | ✗ | - |
| Jan 18, 2021 | Jan 20, 2021 | Ciulla Thomas | Chief Medical Officer | Neutral | 90.0 | +103,125 | 68.75% | ✗ | - |
| Jan 6, 2021 | Jan 7, 2021 | WHITMORE BRADFORD T | 10% Owner | Buy | 92.5 | +350,750 | 5.83% | ✗ | $1000K |
| Dec 24, 2020 | Dec 28, 2020 | WHITMORE BRADFORD T | 10% Owner | Buy | 72.5 | +51,195 | 0.86% | ✗ | $99.9K |
| Dec 21, 2020 | Dec 23, 2020 | LASEZKAY GEORGE M | CEO | Sell | 50.0 | -3,330 | -1.10% | ✓ | $6.9K |
| Dec 2, 2020 | Dec 2, 2020 | WHITMORE BRADFORD T | 10% Owner | Buy | 72.5 | +53,900 | 0.91% | ✗ | $105.1K |
| Nov 24, 2020 | Nov 24, 2020 | WHITMORE BRADFORD T | 10% Owner | Buy | 82.5 | +62,000 | 1.06% | ✗ | $102K |
| Nov 16, 2020 | Nov 16, 2020 | WHITMORE BRADFORD T | 10% Owner | Buy | 82.5 | +62,000 | 1.07% | ✗ | $104.9K |
| Sep 22, 2020 | Sep 24, 2020 | LASEZKAY GEORGE M | CEO | Sell | 41.3 | -13,411 | -4.24% | ✓ | $21.3K |
| Aug 18, 2020 | Aug 18, 2020 | Humphries William D. | Director | Buy | 90.0 | +5,586 | 100.00% | ✗ | $9.9K |
| Aug 12, 2020 | Aug 13, 2020 | WHITMORE BRADFORD T | 10% Owner | Buy | 92.5 | +350,000 | 6.44% | ✗ | $571.7K |
| Aug 12, 2020 | Aug 13, 2020 | WHITMORE BRADFORD T | 10% Owner | Buy | 92.5 | +350,000 | 9.27% | ✗ | $571.7K |